Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(11%)
Results Posted
50%(3 trials)
Terminated
1(11%)

Phase Distribution

Ph early_phase_1
1
11%
Ph not_applicable
1
11%
Ph phase_2
3
33%
Ph phase_1
4
44%

Phase Distribution

5

Early Stage

3

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
4(44.4%)
Phase 2Efficacy & side effects
3(33.3%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Not yet recruiting1
Active, not recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (11.1%)
Phase 14 (44.4%)
Phase 23 (33.3%)
N/A1 (11.1%)

Trials by Status

not_yet_recruiting111%
active_not_recruiting111%
completed667%
terminated111%

Recent Activity

1 active trials
Showing 5 of 9
not_yet_recruitingphase_1

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

NCT07709741
active_not_recruitingphase_2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

NCT06790290
completedphase_2

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

NCT03529773
terminatedphase_2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

NCT03572062
completedearly_phase_1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

NCT03718390
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT07709741Phase 1

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

Not Yet Recruiting
NCT06790290Phase 2

Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants

Active Not Recruiting
NCT03529773Phase 2

A Study to Describe the Safety and Immunogenicity of a RSV Vaccine in Healthy Adults

Completed
NCT03572062Phase 2

A Study to Evaluate the Safety and Immunogenicity of an Adjuvanted RSV Vaccine in Healthy Older Adults

Terminated
NCT03718390Early Phase 1

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Completed
NCT02426632Phase 1

Study to Evaluate Taste Profile of Different JNJ-53718678 Oral Liquid Formulations in Healthy Participants

Completed
NCT00848744Not Applicable

Comparison of Two Salicylic Acid Formulations

Completed
NCT00495274Phase 1

Bioequivalence and Food Effect Study in Healthy Volunteers

Completed
NCT00548769Phase 1

Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients

Completed

All 9 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
9